Besides these, Xie et al. (2015) established a multi-index prediction model based on the six kinds of biomarkers (CEA, CA199, H.P., P53, PG I, and PG II), which was designed to achieve early screening and therapeutic evaluation of GC patients. The gene discussed is JUP; the disease is gastric cancer.